MECHANISM OF RESISTANCE TO CARBAPENEM IN CLINICAL ISOLATES OF BACTEROIDES-FRAGILIS

Citation
I. Podglajen et al., MECHANISM OF RESISTANCE TO CARBAPENEM IN CLINICAL ISOLATES OF BACTEROIDES-FRAGILIS, Medecine et maladies infectieuses, 24, 1994, pp. 590-593
Citations number
NO
Categorie Soggetti
Infectious Diseases
ISSN journal
0399077X
Volume
24
Year of publication
1994
Pages
590 - 593
Database
ISI
SICI code
0399-077X(1994)24:<590:MORTCI>2.0.ZU;2-H
Abstract
Carbapenem (imipenem [IMI], meropenem [MER]) resistance in clinical is olates of Bacteroides fragilis is due to the production of a carbapene mase, a Zn++-dependent metallo beta-lactamase, encoded by the gene cfi A. This gene is carried by ca. 3 % of the B. fragilis strains isolated in France, but is expressed (MICs of IMI, MER greater-than-or-equal-t o 64 mug/ml) in only one third of the cases, and silent (MICs of IMI/M ER = 1/2 mug/ml) in the remaining two thirds. Activation of the silent gene occurs, in vitro and in vivo, after insertion of an IS element, most frequently IS1186, carrying a strong promoter, immediately upstre am of the gene. The cfiA-positive strains differ from the cfiA-negativ e strains in that they harbor the IS elements known in B. fragilis (IS 4351, IS1186, IS942) and they constitute, on the basis of molecular ty ping and sequencing of 16S RNA genes, a distinct taxonomical unit.